secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protalix BioTherapeutics, Inc. (PLX)
CIK:        0001006281
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001104659-26-013498
Event type: other_material
Sentiment:  neutral
Materiality: 0.01
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protalix BioTherapeutics posts February 2026 corporate presentation to website; no material new data disclosed
--------------------------------------------------------------------------------

- Company filed Form 8-K indicating a corporate presentation was posted on February 11, 2026.
- Exhibit 99.1 consists solely of a title slide with no specific financial or pipeline updates.
- No new guidance, clinical data, or business developments were provided in the furnished exhibit.
- Investors would need to access the full presentation on the company website for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006281/000110465926013498/0001104659-26-013498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006281/000110465926013498/plx-20260211x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-013498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer